Tazotex

“Extended Spectrum & Extensive Reach”

Tazotex is a combination of extended-spectrum penicillin Piperacillin and the β- lactamase inhibitor Tazobactam. Penitrax (Piperacillin/Tazobactam) is time tested, well documented and FDA approved antibiotic to treat moderate, severe to life threading infections.

Indications:

Tazotex is indicated for the treatment of Lower Respiratory Tract Infections (LRTIs), Hospital Acquire Pneumonia (HAP), Ventilator Associated Pneumonia (VAP), Healthcare Associated Pneumonia (HCAP), Febrile Neutropenia, Intra Abdominal Infections (IAIs), Surgical Wounds, Skin & Soft Tissues Infections (SSTIs), Diabetic Foot Infections (DFIs), Burn infections, Urinary tract Infections (UTIs), Severe Sepsis and Pediatric Nosocomial Infections.

Dosage Guidelines:

Adults and children over 12 year and older: In general, the recommended total daily dosage is 12 g Piperacillin/1.5 gm Tazobactam given in divided doses (i.e. 4.5 gm every 8 hrs) administered intravenously typically over 30 min. Dose as high as 18 g piperacillin/2.25 g Tazobactam per day in divided doses can be used in severe infections. It can also be administered by Extend infusion or continuous infusion over four hours.

Availability:

Tazotex (Piperacillin/Tazobactam) is available in two strengths 2.25 gm and 4.5 gm in pack of single vial with WFI.